In the current market session, Regeneron Pharmaceuticals Inc. REGN share price is at $695.58, after a 0.06% decrease. Over the past month, the stock spiked by 2.93%, but over the past year, it ...

Mangione's supporters started lining up outside the courthouse around 4 a.m., hoping to get a seat for his afternoon ...

After the Duchess of Sussex announced her American Riviera Orchard rebrand, she once again is facing accusations of ...

Meghan Markle included a sentimental nod to her husband Prince Harry in the logo for her lifestyle brand As Ever, formerly ...

The drug started a phase 2 trial in 2018, but, while it was still listed as an active programme in the company's July pipeline update, there has been no news for some time. Regeneron also said it ...

This week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...